Creatv MicroTech Inc

Creatv MicroTech Inc. is a privately held company located in Potomac, Maryland. The company employs 11 people and generates approximately $7 million in annual revenue. Creatv MicroTech Inc. develops and markets the CellSieve diagnostic platform, a blood test designed for early cancer detection. This innovative test can identify cancer in its earliest stages, even before symptoms appear, and can also confirm a patient's response to treatment and monitor for early signs of recurrence after treatment. The company's technology focuses on identifying cancer-associated macrophage-like cells (CAMLs), a previously unknown cell type found in the blood of cancer patients. What sets Creatv MicroTech Inc. apart is its unique ability to detect cancer at its earliest stages using CAMLs. Unlike circulating tumor cells (CTCs), CAMLs are present in all stages of cancer, including stage I, offering a comprehensive approach to cancer detection, monitoring, and recurrence surveillance. Creatv MicroTech Inc. can be reached through its website, creatvbio.com.